Posted by Michael Wonder on 10 Apr 2020
Ensuring access to medications in the US during the COVID-19 pandemic
9 April 2020 - The coronavirus disease 2019 (COVID-19) pandemic continues to rapidly evolve.
Given the origins of COVID-19 in China, there were initial concerns regarding medication shortages due to the reliance of the US on overseas manufacturing of active pharmaceutical ingredients. Although no major disruptions in pharmaceutical access have occurred thus far, the future of the pandemic and its effect on the US drug supply remains far from certain.
The pharmaceutical supply chain represents a series of interdependent steps that ultimately produce the products that are used by consumers in the US.
